(Total Views: 338)
Posted On: 06/29/2017 5:55:30 PM
Post# of 72446
Re: starboardtack #35419
Dr. Jerry, missed the recent run from 60s to 90s?
Another false statement. A Phase 3 for K-OC would be much smaller than ABSSSI. Clovis' Rubraca was approved after just 106 patients this year.
"Approval of rucaparib and the FoundationFocus CDxBRCA test was based on data from two multicenter, single-arm, open label clinical trials that evaluated the efficacy of rucaparib in 106 patients with advanced ovarian cancer who had progressed after treatment with two or more prior chemotherapies."
https://www.fda.gov/drugs/informationondrugs/...533891.htm
I also showed you the case for a Prurisol Phase 3 here. What else do you got?
https://investorshangout.com/post/view?id=4632616
Another false statement. A Phase 3 for K-OC would be much smaller than ABSSSI. Clovis' Rubraca was approved after just 106 patients this year.
"Approval of rucaparib and the FoundationFocus CDxBRCA test was based on data from two multicenter, single-arm, open label clinical trials that evaluated the efficacy of rucaparib in 106 patients with advanced ovarian cancer who had progressed after treatment with two or more prior chemotherapies."
https://www.fda.gov/drugs/informationondrugs/...533891.htm
I also showed you the case for a Prurisol Phase 3 here. What else do you got?
https://investorshangout.com/post/view?id=4632616
Quote:
It will not be significantly different for any other phase 3.
(5)
(0)
